Rapidly testing hundreds of thousands of DNA sequences, scientists identified specific genetic variations contributing to blood pressure, cholesterol, and blood sugar.

Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s prostate cancer candidate VIR-5500 through a collaboration that could generate more than $1.7 billion for the San ...

Matthew Downham, CEPI’s director of manufacturing and supply chain networks, tells GEN, “Through this partnership, CEPI and Samsung Biologics will establish a pre-agreed, ready-to-activate ...

A pioneer in muscle-tissue engineering is highlighting the challenges of bringing novel therapies to the clinic.

The Taylor vortex fermenter-extractor-separator is designed for small volume, value-added cellular products and process intensification.

Reporting from AGBT in Orlando, Julianna LeMieux checks in with Kevin Davies to review key announcements from the meeting.

Researchers say study identifies location of oligodendrocytes in the brain, and integrates information about gene expression and the structural features of neurons.

Apheris's ADMET Network will combine proprietary datasets in a privacy-preserving environment to accelerate AI drug discovery models.

HYDRACs are a class of proteomimetic polymers designed to mark harmful proteins, like MYC and KRAS, for destruction rather than merely block their activity.

Beam is advancing BEAM-304 using an approach in which multiple mutation-specific base editors are developed within a single clinical program.

In this GEN webinar, experts from ChemPartner, Philip Clarke, PhD, Hu Liu, PhD, and Greg Liang, MD, will provide an overview of some of the innovative platforms that are shaping the next-generation of ...

Tamarind’s platform for model coordination and inference enables user-friendly AI tools for life science researchers.